Learn more about us

I was never smart enough to buy at the bottom, nor sell at the top ... Bernard Baruch, Legendary Investor

My name is Tarun Chandra, and I am the Founder and Editor of the newsletter service. The objective is to empower DIY and millennial investors with portfolio products that aim to outperform the market consistently over a period of time by leveraging quantitative techniques and system-driven investing.

Graycell Advisors is a publisher of stock newsletters. We presently have 3 services - Prudent Small Cap, Prudent Biotech, and Prudent Healthcare, and more can be learned here.

As someone who has worked as an Analyst on Wall Street for many years, and on Main Street in Corporate Strategy and Finance roles at technology services companies, I understand the mechanics of investing and corporate performance. I've been building quantitative models for many years focusing on different sectors and segments of the market including Small, Mid and Large caps, and S&P 500 companies. My academic graduate background is in Finance, as well as in Systems Analysis & Design.

A more sit back and read kind of background story is presented in the section on Systematic Investing.

If you subscribe to the newsletters, I hope we are able to contribute to your investment objectives and build investment wealth over time.

If you are an asset manager or institution, please contact us.

Graycell Advisors, and its affiliates, officers, employees, families, and all other related parties, collectively referred to as ‘Graycell’ and/or ‘we,’ is a publisher of financial information, such as the Smallcap, and Prudent Biotech newsletters. We are not a Registered Investment Advisor (RIA). Historical performance figures provided are hypothetical and unaudited, and based on our proprietary analysis and system performance, back-tested over an extended period of time. Hypothetical or simulated performance results have limitations, and unlike an actual performance record, simulated results do not represent actual trading. The performance results obtained are intended for illustrative purposes only. No representation is being made that an account will or is likely to achieve profit or losses similar to those shown. Past performance is not indicative of future results, which may vary. All stock and related investments have a degree of risk, which can result in a significant or total loss. In addition, biotech sector and smallcaps are characterized by much higher risk and volatility than the general stock market. Information contained herein is general and does not constitute a personal recommendation or takes into account the particular investment objectives, financial situations, or needs of individual investors. If you decide to invest in any of the stocks of the companies mentioned in the newsletters, samples, alerts, etc., sent to you or available on our websites, you can and may lose some or all of your investment. You alone are responsible for your investment decisions. Use of the information herein is at one's own risk. We are simply sharing the results of our model. Nothing should be construed as a recommendation or an offer to buy or sell any securities, and we are not liable nor do we assume any liability or responsibility for losses incurred as a result of any information provided or not provided or not made available in a timely manner, herein or on our website or using any other medium. We cannot guarantee the accuracy and completeness of any information furnished by us. We may or may not have existing positions in the stocks mentioned in our reports. Our models are proprietary and/or licensed, and can be changed or revised based on our discretion at any time without any notification. Subscribers and investors should always conduct their own due diligence with any potential investment, and consider obtaining professional advice before making an investment decision.
© Graycell Advisors. All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Graycell Advisors is strictly prohibited and shall be deemed to be copyright infringement.